Voluntary health deals touted by Trump team face weak enforcement and uncertain future

During a campaign stop in Michigan, Rep. Tom Barrett accompanied HHS Secretary Robert F. Kennedy Jr. to an apple orchard, where they highlighted the Trump administration’s voluntary health-industry pacts, including a plan to phase out certain synthetic food dyes and to lower drug prices through “most-favored-nation” agreements. While the announcements generated media fanfare, the arrangements are loosely defined, lack robust monitoring, and depend on companies’ goodwill.

Follow-up reports show that fewer than 30% of pledged food manufacturers have eliminated the targeted dyes, and major firms such as Coca-Cola and Unilever have offered no firm commitments. An insurer pledge to cut prior-authorization requirements has resulted in only an 11% reduction, with no public dashboards launched to track compliance. Health experts and watchdog groups warn that the opacity and limited enforcement could cause the initiatives to fade once political attention wanes, potentially undermining voter confidence ahead of the midterms.